Advanced Search

    column
    Major Advances in Clinical Oncology 2005
    WU Yi-long
    2006, 6(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2006.02.001
    Abstract PDF
    American Society of Clinical Oncology Annual Report--Clinical Cancer Advances 2005
    DONG Song, ZHU Jian-quan, WU Yi-long
    2006, 6(2): 67-73. DOI: 10.3969/j.issn.1671-5144.2006.02.002
    Abstract PDF
    Trastuzumab Plus Adjuvant Chemotherapy Improves Survival of Operable HER-2 Positive Breast Cancer
    RAO Nan-yan, SHAO Zhi-min, WANG Kun
    2006, 6(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2006.02.003
    Abstract PDF
    Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome
    WANG Shen-ming, YIN Heng-hui, LI Xue-rui
    2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
    Abstract PDF
    Evaluation on Parallel HER-2 Testing of Both FISH and Immunohistochemistry in Breast Cancer Tissues
    LIU Yan-hui, ZHANG Guo-chun
    2006, 6(2): 81-83. DOI: 10.3969/j.issn.1671-5144.2006.02.005
    Abstract PDF
    Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel,and Epirubicin Chemotherapy
    SHEN Kun-wei, LIAO Ning
    2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
    Abstract PDF
    Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel,with or without Trastuzumab in Breast Cancer
    XU Bing-he, LIN Xue-ting
    2006, 6(2): 87-89. DOI: 10.3969/j.issn.1671-5144.2006.02.007
    Abstract PDF
    Results of Two Open-label, Multicenter Phase Ⅱ Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER-2 Positive Advanced Breast Cancer
    JIANG Ze-fei, ZHENG Deng-yun
    2006, 6(2): 90-92. DOI: 10.3969/j.issn.1671-5144.2006.02.008
    Abstract PDF
    Terbinafine in Fungal Infections of the Nails:a Meta-analysis of Randomized Double-blind Clinical Trials
    WANG Qun, HAN Yong-zhi
    2006, 6(2): 93-96. DOI: 10.3969/j.issn.1671-5144.2006.02.009
    Abstract PDF
    The Prevalence and Clinical Features of Inpatients with Diabetes
    YANG Hua-zhang, KUANG Jian, YU Gui-fang, LIU Li-hong, PEI Jian-hao, CHEN Zhong, CHEN Hong-mei, CHEN Liang, LI Zhong-wen, WU Ying, HE Peng-cheng, LI Juan, HUANG Xiao-ying
    2006, 6(2): 97-100. DOI: 10.3969/j.issn.1671-5144.2006.02.010
    Abstract PDF
    Tadalafil for Erectile Dysfunction:a Systematic Review of Randomized Trials
    REN Ming-liang, JIANG Jun, LAN Wei-hua
    2006, 6(2): 101-104. DOI: 10.3969/j.issn.1671-5144.2006.02.011
    Abstract PDF
    Brief Introduction to Common Bias of Systematic Reviews
    ZHANG Qian, XUE Qian
    2006, 6(2): 105-108. DOI: 10.3969/j.issn.1671-5144.2006.02.012
    Abstract PDF
    Principles for International Registration of Protocol Information and Results from Human Trials of Health-related Interventions-The Ottawa Statement, Part One
    LIU Jian-ping, ZHANG Jing, CHEN Jun-chao
    2006, 6(2): 109-112. DOI: 10.3969/j.issn.1671-5144.2006.02.013
    Abstract PDF
    NCCN Fever and Neutropenia Practice Guidelines
    CHU Qian, YU Shi-ying
    2006, 6(2): 113-125. DOI: 10.3969/j.issn.1671-5144.2006.02.014
    Abstract PDF
    Could Lung Cancer Patients without Accurate Pathological Diagnosis Get the Anticancer Treatment?
    , , ,
    2006, 6(2): 126-128. DOI: 10.3969/j.issn.1671-5144.2006.02.015
    Abstract PDF